On Friday, Bio-Techne Corp (NASDAQ: TECH) opened lower -3.02% from the last session, before settling in for the closing price of $68.81. Price fluctuations for TECH have ranged from $51.79 to $89.91 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 12.42%. Company’s average yearly earnings per share was noted -11.24% at the time writing. With a float of $155.57 million, this company’s outstanding shares have now reached $157.64 million.
Considering the fact that the conglomerate employs 3050 people, you should pay attention to its efficiency factor.
Bio-Techne Corp (TECH) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Bio-Techne Corp is 1.03%, while institutional ownership is 100.30%. The most recent insider transaction that took place on Mar 07 ’24, was worth 800,627. In this transaction Director of this company sold 10,400 shares at a rate of $76.98, taking the stock ownership to the 43,097 shares. Before that another transaction happened on Aug 30 ’23, when Company’s Director sold 8,939 for $80.32, making the entire transaction worth $717,959. This insider now owns 51,872 shares in total.
Bio-Techne Corp (TECH) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2023, the company posted $0.4 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at $0.41) by -$0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -11.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.59% during the next five years compared to 16.30% growth over the previous five years of trading.
Bio-Techne Corp (NASDAQ: TECH) Trading Performance Indicators
Check out the current performance indicators for Bio-Techne Corp (TECH). In the past quarter, the stock posted a quick ratio of 3.03. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.16. Likewise, its price to free cash flow for the trailing twelve months is 46.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.39, a number that is poised to hit 0.45 in the next quarter and is forecasted to reach 2.05 in one year’s time.
Technical Analysis of Bio-Techne Corp (TECH)
Compared to the last year’s volume of 1.07 million, its volume of 0.97 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 38.62%. Additionally, its Average True Range was 2.10.
During the past 100 days, Bio-Techne Corp’s (TECH) raw stochastic average was set at 34.04%, which indicates a significant increase from 8.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.89% in the past 14 days, which was higher than the 31.62% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $70.74, while its 200-day Moving Average is $72.06. Nevertheless, the first resistance level for the watch stands at $68.07 in the near term. At $69.42, the stock is likely to face the second major resistance level. The third major resistance level sits at $70.31. If the price goes on to break the first support level at $65.83, it is likely to go to the next support level at $64.94. Should the price break the second support level, the third support level stands at $63.59.
Bio-Techne Corp (NASDAQ: TECH) Key Stats
There are currently 157,192K shares outstanding in the company with a market cap of 10.49 billion. Presently, the company’s annual sales total 1,137 M according to its annual income of 285,260 K. Last quarter, the company’s sales amounted to 272,600 K and its income totaled 27,470 K.
